# PDE8B

## Overview
The PDE8B gene encodes the protein phosphodiesterase 8B, which is a member of the phosphodiesterase family, specifically categorized as a high-affinity, cAMP-specific phosphodiesterase. This enzyme plays a pivotal role in the regulation of intracellular cyclic adenosine monophosphate (cAMP) levels, a critical second messenger involved in various cellular processes. PDE8B is predominantly expressed in the adrenal gland, thyroid, Leydig cells, and pancreatic β-cells, where it modulates processes such as steroidogenesis, thyroid hormone production, testosterone synthesis, and insulin secretion, respectively. The gene is composed of 22 exons and produces several splice variants, indicating potential alternative regulatory mechanisms. Mutations in PDE8B have been linked to clinical conditions such as adrenal hyperplasia, isolated micronodular adrenocortical disease, Cushing's syndrome, and autosomal-dominant striatal degeneration, highlighting its significance in both endocrine and neurological health (ArnaudLopez2008Phosphodiesterase; Gamanuma2003Comparison; Horvath2008A).

## Structure
The PDE8B protein is encoded by the PDE8B gene and consists of 885 amino acids, with a predicted molecular mass of approximately 98,978 Da (Gamanuma2003Comparison). The primary structure includes a PAS domain located between residues 269-334 and a PDE catalytic domain between residues 614-852 (Gamanuma2003Comparison). The PAS domain functions as a signal sensor, while the PDE catalytic domain is responsible for the enzyme's activity (Gamanuma2003Comparison). The protein also contains three putative phosphorylation sites for cAMP- and cGMP-dependent protein kinases, situated between the PAS and PDE domains, which may influence its activity and stability (Gamanuma2003Comparison).

The PDE8B gene is composed of 22 exons and 21 introns, with the PAS domain encoded by exons 7-8 and the PDE catalytic domain by exons 17-20 (Gamanuma2003Comparison). Splice variants such as PDE8B2, PDE8B3, and PDE8B4 have been identified, differing in specific protein regions, which may suggest alternative regulatory mechanisms (Gamanuma2003Comparison). The sequence identity between PDE8B and its closely related PDE8A1 is 68%, indicating evolutionary conservation (Gamanuma2003Comparison). The tertiary and quaternary structures are not detailed in the available context.

## Function
Phosphodiesterase 8B (PDE8B) is a high-affinity, cAMP-specific phosphodiesterase that plays a crucial role in regulating intracellular cAMP levels, which are vital for various cellular processes. In the adrenal gland, PDE8B is involved in modulating adrenal steroidogenesis by controlling cAMP-dependent protein kinase (PKA) activity and cAMP-dependent transcription. This regulation is essential for maintaining appropriate levels of steroid hormone production, as evidenced by increased steroidogenesis upon PDE8B inhibition or genetic ablation (Tsai2010The; Tsai2012Regulation).

PDE8B is also expressed in the thyroid, where it influences thyroid-stimulating hormone (TSH) signaling by hydrolyzing cAMP, thereby affecting the production of thyroid hormones T4 and T3. This activity is crucial for regulating metabolism, growth, and development (ArnaudLopez2008Phosphodiesterase).

In Leydig cells, PDE8B, along with PDE8A, helps maintain low cAMP levels, suppressing resting steroidogenesis and modulating the response to hormonal stimulation. This regulation is important for controlling testosterone production and other steroidogenic processes (ShimizuAlbergine2012cAMPSpecific).

PDE8B's role extends to pancreatic β-cells, where it influences insulin secretion by modulating cAMP pools involved in insulin granule recruitment and trafficking, highlighting its importance in glucose metabolism (Dov2007Diminished).

## Clinical Significance
Mutations and alterations in the PDE8B gene are associated with several clinical conditions. Mutations in PDE8B have been linked to adrenal hyperplasia, a condition characterized by the enlargement of the adrenal glands. Specific mutations, such as c.914A4T/H305P, have been identified in patients with isolated micronodular adrenocortical disease (iMAD) and Cushing's syndrome, leading to increased cAMP levels and affecting adrenal function (Horvath2008A). PDE8B mutations are also implicated in autosomal-dominant striatal degeneration (ADSD), a rare movement disorder affecting the striatum, resulting in symptoms similar to Parkinson's disease (Appenzeller2010AutosomalDominant).

Alterations in PDE8B expression have been associated with thyroid dysfunction. Variants in the PDE8B gene, such as SNP rs4704397, have been linked to variations in serum thyroid-stimulating hormone (TSH) levels, potentially contributing to hypothyroidism and recurrent miscarriage (Granfors2012Phosphodiesterase; ArnaudLopez2008Phosphodiesterase). These genetic variations may affect the regulation of cAMP levels, influencing thyroid hormone production and TSH release (ArnaudLopez2008Phosphodiesterase).


## References


[1. (ArnaudLopez2008Phosphodiesterase) Lisette Arnaud-Lopez, Gianluca Usala, Graziano Ceresini, Braxton D. Mitchell, Maria Grazia Pilia, Maria Grazia Piras, Natascia Sestu, Andrea Maschio, Fabio Busonero, Giuseppe Albai, Mariano Dei, Sandra Lai, Antonella Mulas, Laura Crisponi, Toshiko Tanaka, Stefania Bandinelli, Jack M. Guralnik, Angela Loi, Lenuta Balaci, Gabriella Sole, Alessia Prinzis, Stefano Mariotti, Alan R. Shuldiner, Antonio Cao, David Schlessinger, Manuela Uda, Gonçalo R. Abecasis, Ramaiah Nagaraja, Serena Sanna, and Silvia Naitza. Phosphodiesterase 8b gene variants are associated with serum tsh levels and thyroid function. The American Journal of Human Genetics, 82(6):1270–1280, June 2008. URL: http://dx.doi.org/10.1016/j.ajhg.2008.04.019, doi:10.1016/j.ajhg.2008.04.019. This article has 101 citations.](https://doi.org/10.1016/j.ajhg.2008.04.019)

[2. (Gamanuma2003Comparison) Michiko Gamanuma, Keizo Yuasa, Takashi Sasaki, Naoki Sakurai, Jun Kotera, and Kenji Omori. Comparison of enzymatic characterization and gene organization of cyclic nucleotide phosphodiesterase 8 family in humans. Cellular Signalling, 15(6):565–574, June 2003. URL: http://dx.doi.org/10.1016/s0898-6568(02)00146-8, doi:10.1016/s0898-6568(02)00146-8. This article has 55 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/s0898-6568(02)00146-8)

[3. (Appenzeller2010AutosomalDominant) Silke Appenzeller, Anja Schirmacher, Hartmut Halfter, Sebastian Bäumer, Manuela Pendziwiat, Vincent Timmerman, Peter De Jonghe, Klára Fekete, Florian Stögbauer, Peter Lüdemann, Margret Hund, Elgar Susanne Quabius, E. Bernd Ringelstein, and Gregor Kuhlenbäumer. Autosomal-dominant striatal degeneration is caused by a mutation in the phosphodiesterase 8b gene. The American Journal of Human Genetics, 86(1):83–87, January 2010. URL: http://dx.doi.org/10.1016/j.ajhg.2009.12.003, doi:10.1016/j.ajhg.2009.12.003. This article has 35 citations.](https://doi.org/10.1016/j.ajhg.2009.12.003)

[4. (ShimizuAlbergine2012cAMPSpecific) Masami Shimizu-Albergine, Li-Chun Lisa Tsai, Enrico Patrucco, and Joseph A. Beavo. Camp-specific phosphodiesterases 8a and 8b, essential regulators of leydig cell steroidogenesis. Molecular Pharmacology, 81(4):556–566, January 2012. URL: http://dx.doi.org/10.1124/mol.111.076125, doi:10.1124/mol.111.076125. This article has 59 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1124/mol.111.076125)

[5. (Horvath2008A) Anelia Horvath, Christoforos Giatzakis, Kitman Tsang, Elizabeth Greene, Paulo Osorio, Sosipatros Boikos, Rossella Libè, Yianna Patronas, Audrey Robinson-White, Elaine Remmers, Jerôme Bertherat, Maria Nesterova, and Constantine A Stratakis. A camp-specific phosphodiesterase (pde8b) that is mutated in adrenal hyperplasia is expressed widely in human and mouse tissues: a novel pde8b isoform in human adrenal cortex. European Journal of Human Genetics, 16(10):1245–1253, April 2008. URL: http://dx.doi.org/10.1038/ejhg.2008.85, doi:10.1038/ejhg.2008.85. This article has 88 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1038/ejhg.2008.85)

[6. (Tsai2012Regulation) L-C. Tsai and J. Beavo. Regulation of adrenal steroidogenesis by the high-affinity phosphodiesterase 8 family. Hormone and Metabolic Research, 44(10):790–794, August 2012. URL: http://dx.doi.org/10.1055/s-0032-1321861, doi:10.1055/s-0032-1321861. This article has 23 citations and is from a peer-reviewed journal.](https://doi.org/10.1055/s-0032-1321861)

[7. (Dov2007Diminished) Avital Dov, Eva Abramovitch, Nasim Warwar, and Rafael Nesher. Diminished phosphodiesterase-8b potentiates biphasic insulin response to glucose. Endocrinology, 149(2):741–748, November 2007. URL: http://dx.doi.org/10.1210/en.2007-0968, doi:10.1210/en.2007-0968. This article has 43 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1210/en.2007-0968)

[8. (Granfors2012Phosphodiesterase) Michaela Granfors, Helena Karypidis, Frida Hosseini, Lottie Skjöldebrand-Sparre, Anneli Stavreus-Evers, Katarina Bremme, Britth-Marie Landgren, Inger Sundström-Poromaa, Anna-Karin Wikström, and Helena Åkerud. Phosphodiesterase 8b gene polymorphism in women with recurrent miscarriage: a retrospective case control study. BMC Medical Genetics, December 2012. URL: http://dx.doi.org/10.1186/1471-2350-13-121, doi:10.1186/1471-2350-13-121. This article has 5 citations and is from a peer-reviewed journal.](https://doi.org/10.1186/1471-2350-13-121)

[9. (Tsai2010The) Li-Chun Lisa Tsai, Masami Shimizu-Albergine, and Joseph A. Beavo. The high-affinity camp-specific phosphodiesterase 8b controls steroidogenesis in the mouse adrenal gland. Molecular Pharmacology, 79(4):639–648, December 2010. URL: http://dx.doi.org/10.1124/mol.110.069104, doi:10.1124/mol.110.069104. This article has 77 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1124/mol.110.069104)